Halozyme Therapeutics, Inc. (HALO)
NASDAQ: HALO · Real-Time Price · USD
45.70
-0.06 (-0.13%)
At close: Nov 21, 2024, 4:00 PM
46.15
+0.45 (0.98%)
After-hours: Nov 21, 2024, 6:34 PM EST

Halozyme Therapeutics Operating Expense Breakdown

History

Date Cost of Sales Selling, General, and Administrative Research and Development Amortization
Sep 30, 2024169.66M149.69M79.94M71.05M
Jun 30, 2024175.06M143.72M78.81M73.63M
Mar 31, 2024185.52M146.96M77.50M73.70M
Dec 31, 2023192.36M149.18M76.36M73.77M
Sep 30, 2023182.18M149.32M77.59M60.56M
Jun 30, 2023174.68M148.52M76.98M67.42M
Mar 31, 2023158.55M167.05M72.73M60.98M
Dec 31, 2022139.30M143.53M66.61M43.15M
Sep 30, 2022118.77M119.55M54.15M38.60M
Jun 30, 202290.04M98.25M45.93M11.40M
Mar 31, 202279.12M53.10M38.52M-
Dec 31, 202181.41M50.32M35.67M-
Sep 30, 202186.10M46.98M32.94M-
Jun 30, 202173.08M45.51M32.21M-
Mar 31, 202155.80M44.16M33.09M-
Dec 31, 202043.37M45.74M34.24M-
Sep 30, 202033.78M59.24M71.97M-
Jun 30, 202050.55M65.52M94.68M-
Mar 31, 202046.68M71.88M119.63M-
Dec 31, 201945.55M77.25M140.80M-
Source: Business metrics provided by Main Street Data and sourced from official company press releases and documents.